Investec Bank Plc has filed a Form 8.5 regulatory disclosure relating to share dealings in Advanced Medical Solutions Group Plc on August 6, 2026.
The disclosure was made under Rule 8.5 of the Takeover Code, which governs public dealing disclosures by exempt principal traders with recognised intermediary status.
Investec Bank Plc is identified in the filing as acting in a client-serving capacity, holding the role of Advisor and Joint Broker to Advanced Medical Solutions Group Plc.
The filing was submitted on August 7, 2026, with the actual share dealings having taken place the previous day on August 6, 2026.
According to the disclosure, Investec Bank Plc purchased a total of 776,000 ordinary shares in Advanced Medical Solutions Group Plc during the dealing period.
The purchases were executed at prices ranging from a low of 280.6 pence per unit to a high of 281 pence per unit.
In addition to the purchases, Investec Bank Plc also recorded sales of 378,666 ordinary shares during the same dealing period.
Those sales were transacted at prices between 280.5 pence per unit at the lowest and 281 pence per unit at the highest.
The filing confirms that no cash-settled or stock-settled derivative transactions, including options, were undertaken as part of these dealings.
Investec Bank Plc also declared that no indemnity arrangements, option agreements, or understandings existed that could have acted as an inducement to deal or refrain from dealing.
The bank further confirmed there were no agreements relating to voting rights or future acquisition and disposal of relevant securities linked to any derivative instrument.
The contact listed for the disclosure is Abhishek Gawde, with dealings reported in accordance with the requirements of the UK Takeover Panel’s regulatory framework.
